Literature DB >> 24977664

Temperature thresholds in assessment of the clinical course of acquired cold contact urticaria: a prospective observational one-year study.

M Estela Martinez-Escala1, Laia Curto-Barredo, Lluïsa Carnero, Ramon M Pujol, Ana M Giménez-Arnau.   

Abstract

Cold contact urticaria is the second most common subtype of physical urticaria. Cold stimulation standardized tests are mandatory to confirm the diagnosis. The aim of this study is to define the utility of determining thresholds (critical time and temperature) in assessment of the clinical course of typical acquired cold contact urticaria. Nineteen adult patients (10 women and 9 men; mean age 45 years) were included in the study and the diagnosis was confirmed with the ice-cube test and TempTest 3.0. Patients were treated continuously for 1 year with 20 mg/day rupatadine (anti-H1). Thresholds measurements were made before and after treatment. Improvements in temperature and critical time thresholds were found in the study sample, demonstrating the efficacy of continuous treatment with rupatadine. In most cases association with a clinical improvement was found. We propose an algorithm for the management of acquired cold contact urticaria based on these results.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24977664     DOI: 10.2340/00015555-1918

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  4 in total

Review 1.  Review of Physical Urticarias and Testing Methods.

Authors:  Mario Sánchez-Borges; Luis González-Aveledo; Fernan Caballero-Fonseca; Arnaldo Capriles-Hulett
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

Review 2.  Urticaria and Angioedema: an Update on Classification and Pathogenesis.

Authors:  Susanne Radonjic-Hoesli; Kathrin Scherer Hofmeier; Sara Micaletto; Peter Schmid-Grendelmeier; Andreas Bircher; Dagmar Simon
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

3.  IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.

Authors:  Ana M Giménez-Arnau; Clara Ribas-Llauradó; Nasser Mohammad-Porras; Gustavo Deza; Ramón M Pujol; Ramón Gimeno
Journal:  Clin Transl Allergy       Date:  2022-02-01       Impact factor: 5.871

4.  Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.

Authors:  Martin Metz; Karsten Weller; Claudia Neumeister; Iñaki Izquierdo; Rolf-Hasso Bödeker; Ulrich Schwantes; Marcus Maurer
Journal:  Dermatol Ther (Heidelb)       Date:  2015-11-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.